facebook pixel
chevron_right Health
transparent transparent
Caspase-2 enzyme inhibitor shows promise for ameliorating fatty liver disease: Researchers identify enzyme as responsible for onset and progression of fatty liver disease in mice and human clinical sp
While explaining how NASH is initiated, our findings also offer a simple and effective way to treat or prevent this devastating disease. NASH is the most aggressive form of non-alcoholic fatty liver disease (NAFLD), which includes a spectrum of chronic liver diseases and has become a leading cause of liver transplants. Using this model, researchers found that the onset of NASH correlated with increased expression of caspase-2.
For the best experience use Awesummly app on your Android phone
Awesummly Chrome Extension Awesummly Android App